Four scientific researches from Instituto Bernabeu selected for the most important congress on reproductive medicine in the United States.

For another year, Instituto Bernabeu’s scientific work has been recognized in the United States with the selection of four of its research studies to be presented at the American Society for Reproductive Medicine (ASRM) Congress, the most important event in its field.

The congress, which will be held in Denver, Colorado, from October 19 to 23, 2024, will bring together internationally renowned specialists in different disciplines related to reproductive medicine.

Dr. Juan Carlos Castillo, Instituto Bernabeu’s Scientific Director, will be in charge of representing Grupo Instituto Bernabeu to present the results of these studies led and participated in by our medical, embryology and molecular genetics teams.

Among the selected studies are: “Exploring the link between estrogen and progesterone receptor polymorphisms and idiopathic thin endometrium” and “The role of patient factors on embryo quality, ploidy and clinical outcomes following assessment by an artificial intelligence (AI) algorithm”.

In addition, other studies will be presented such as “Continuous ovarian stimulation: a proof-of-concept study exploring the uninterrupted use of corifollitropin alpha in duostim cycles for enhanced efficiency and patient convenience (Alicante protocol)”, which has been recognized by the journal Fertility and Sterility Reports as the best article of 2024.

In addition to the above, the study entitled “Improving Blastulation With Ai-Powered Real-Time Motility Analysis Of Single Sperm During ICSI”, which explores the use of real-time sperm motility analysis using artificial intelligence during ICSI and in which Dr. Jorge Ten, director of the embryology laboratory at Instituto Bernabeu participated, was also one of the outstanding studies in poster format.